MedPage Today on MSN
ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first ...
Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...
Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following ...
Candy graduated from Mount Sinai’s nursing program at City College of New York and by 1975 was working in the neonatal unit ...
Who says you can’t go home again? In the world of Grey’s Anatomy, not even death can keep characters from returning to the ...
Media seeking NAPT materials can access assets here.
To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...
To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...
The highest Islamic religious authority in Australia has condemned the alleged Bondi shooters as their links to the terror ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback